PIONEERING THE POSSIBLE

Serial Number 88218037
602

Registration Progress

Application Filed
Dec 5, 2018
Under Examination
Jun 11, 2019
Approved for Publication
Apr 16, 2019
Published for Opposition
Apr 16, 2019
Registered

Basic Information

Serial Number
88218037
Filing Date
December 5, 2018
Published for Opposition
April 16, 2019
Abandonment Date
December 19, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jan 2, 2023
Classes
042

Rights Holder

Editas Medicine, Inc.

03
Address
11 Hurley Street
Cambridge, MA 02141

Ownership History

Editas Medicine, Inc.

Original Applicant
03
Cambridge, MA

Editas Medicine, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description
Jan 3, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 2, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 2, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 30, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 30, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 30, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 30, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN
Jun 17, 2022 GNRT F NON-FINAL ACTION E-MAILED
Jun 17, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 15, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 10, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 10, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 10, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 10, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 10, 2022 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 10, 2022 IUAF S USE AMENDMENT FILED
Nov 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 12, 2021 EX5G S SOU EXTENSION 5 GRANTED
Nov 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 5, 2021 EXT5 S SOU EXTENSION 5 FILED
May 21, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 19, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
May 19, 2021 EXT4 S SOU EXTENSION 4 FILED
May 19, 2021 EX4G S SOU EXTENSION 4 GRANTED
Dec 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 9, 2020 EXT3 S SOU EXTENSION 3 FILED
Dec 9, 2020 EX3G S SOU EXTENSION 3 GRANTED
May 12, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 8, 2020 EXT2 S SOU EXTENSION 2 FILED
May 8, 2020 EX2G S SOU EXTENSION 2 GRANTED
Nov 9, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 7, 2019 EXT1 S SOU EXTENSION 1 FILED
Nov 7, 2019 EX1G S SOU EXTENSION 1 GRANTED
Jun 11, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 16, 2019 PUBO A PUBLISHED FOR OPPOSITION
Apr 16, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2019 DOCK D ASSIGNED TO EXAMINER
Dec 26, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Medical and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
First Use Anywhere: Dec 17, 2019
First Use in Commerce: Dec 17, 2019

Classification

International Classes
042